MedPath

Phase I/II trial of efficacy and safety of carbon-ion radiotherapy for primary malignant bone and soft tissue tumor (GUNMA0904)

Phase 1
Recruiting
Conditions
Primary malignant bone and soft tissue tumor
Registration Number
JPRN-UMIN000009720
Lead Sponsor
Gunma University Heavy-ion Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) Primary head tumor 2) Obvious intravascular embolus in radiographics 3) Artifact affecting dose caliculation 4) Obivious tumor invasion to bowels 5) Past history of chemotherapy within 4 weeks before treatment 6) Uncontrolled infectious disease 7) Past history of irradiation to the target 8) Uncontrolled severe complication 9) Active double cancers 10) In pregnancy or during the lactation preiod 11) Other medical or psychological unsuitable reasons

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ocal control rate at 2 years
Secondary Outcome Measures
NameTimeMethod
Response rate, progression-free survival rate, overall survival rate, acute complication rate, late complication rate, QO
© Copyright 2025. All Rights Reserved by MedPath